References
- Shriver D A, Rosenthale M E, Kluender H C, Schut R N, McGuire J L, Hong E. Pharmacology of riop-rostil, a new gastric cytoprotective/antisecretory agent. Arzneim Forsch/Drug Res 1985; 35(1)839–843
- Demol P, Wingender W, Weihrauch T R, Graefe K H. Inhibition of gastric secretion in man by riop-rostil, a new synthetic methyl prostaglandin E. Arzneim Forsch/Drug Res 1985; 35(1)861–863
- Demol P, Smitz H D, Weihrauch T R, Kuhlmann J. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E, analogue rioprostil. Arzneim Forsch/Drug Res 1986; 36(11)1406–1408
- Dunn O J. Nonparametric statistical methods. Wiley & Sons, New York 1973, Chapter 6.3.B
- Gerova Z, Pashankov P. Farmacija 1984; 1: 7–11
- Tallarida R J, Murray R B. Manual of pharmacologic calculations with computer programs. Springer- Verlag, New York 1981
- Stiel D, Ellard K T, Hills U, Brooks P M. Protective effect of enprostil against aspirin-induced gas-troduodenal mucosal injury in man. Am J Med 1986; 81(Suppl 2A)54–58
- Wilson D. Advances in prostaglandin and gastroenterology. HI International Symposium. 8th World Congress Gastroenterol, San Paolo, Sept, 1986, 7–12